EBACU   $11.3  3.67% Market Open

European Biotech Acquisition Corp
Last Events:

2023-03-29 Trend pattern changed from нисходящий треугольник to симметричный треугольник.

2023-03-29 Signal in Stochastic changed from bullish to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

2023-03-29 Signal in MACD changed from bearish reversal to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: entrance to the overbought zone.

2023-03-29 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-03-29 Trend Power changed from slow to strong.

2023-03-29 Trend pattern changed from симметричный треугольник to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bearish to bullish. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: signal line crossed the middle level.

2023-03-29 Signal in MACD changed from bullish weakening to bearish reversal. Oscillator MACD is in the positive territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the tendency to growth. Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - Buy ActivelyBuy
rsi Sell - ActivelyBuy
macd Sell ActivelyBuy -
stoch - Buy -
ma20 - - -
ma50 - - -
ma100 - - -
ISIN KYG3167F1101
ceo Mr. Eduardo Bravo Fernandez de Araoz
Website https://www.lspvc.com/ebac
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on business in the life sciences industry in Europe. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.